Skip to main content
. 2016 Jun 10;7:863. doi: 10.3389/fmicb.2016.00863

Table 2.

Primers used to test for the presence of virulence genes.

Target gene Primers Fragment size (pb)
Agg AAGAAAAAGAAGTAGACCAAC AAACGGCAAGACAAGTAAATA 1,553
GelE ACCCCGTATCATTGGTTT ACGCATTGCTTTTCCATC 419
esp TTGCTAATGCTACTCCACGACC GCGTCAACACTTGCATTGCCGAA 933
efaAfs GACAGACCCTCACGAATA AGTTCATCATGCTGTAGTA 705
efaAfm AACAGATCCGCATGAATA CATTTCATCATCTGATAGTA 735
cpd TGGTGGGTTATTTTTCAATTC TACGGCTCTGGCTTACTA 782
Cob AACATTCAGCAAACAAAGC TTGTCATAAAGAGTGGTCAT 1,405
Ccf GGGAATTGAGTAGTGAAGAAG AGCCGCTAAAATCGGTAAAAT 543
cylLL GATGGAGGGTAAGAATTATGG GCTTCACCTCACTAAGTTTTATAG 253
cylLS GAAGCACAGTGCTAAATAAGG GTATAAGAGGGCTAGTTTCAC 240
cylM AAAAGGAGTGCTTACATGGAAGAT CATAACCCACACCACTGATTCC 2,940
cylB AAGTACACTAGTACAACTAAGGGA ACAGTGAACGATATAACTCGCTATT 2,020
CylA TAGCGAGTTATATCGTTCACTGTA CTCACCTCTTTGTATTTAAGCATG 1,282

Agg (Aggregation protein), gelE (gelatinase), esp (cell-wall-associated protein) efaAfm and efaAfs (cell wall adhesins), cpd, cob and ccf (sex pheromones, chemotactic for human leukocytes, facilitate conjugation), cylLL and cylLS (Cytolysin precursor), cylM (post-translational modification of cytolysin), cylB (transport of cytolysin) and cylA (activation of cytolysin).

HHS Vulnerability Disclosure